OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study

Domínguez, Clara; Pozo‐Rosich, Patricia; Torres‐Ferrús, Marta; Hernández-Beltrán, Natalia; Jurado‐Cobo, C.; González‐Oria, C.; Santos, S; J Monzón, M; Latorre, G.; C Alvaro, L; M. Gago, A.; Mercedes Gallego, María; Medrano, V; Huerta Villanueva, Mariano; García-Alhama, Jessica; Belvís, R.; Leira, Yago; Leira, Rogelio

doi:10.1111/ene.13523

Public

OnabotulinumtoxinA in chronic migraine: predictors of response. A prospective multicentre descriptive study

Published in European Journal of Neurology • Nov 24, 2017

Authors:

Clara Domínguez

Patricia Pozo‐Rosich

Marta Torres‐Ferrús

Abstract

BACKGROUND AND PURPOSE: OnabotulinumtoxinA is a treatment specifically approved for the prophylaxis of chronic migraine in adults. The aim of this study was to assess the effectiveness of OnabotulinumtoxinA in chronic migraine after 1 year of treatment in a real-life setting and to identify clinical...

Subject

Medicine

Chronic Migraine

Migraine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!